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Long Runs of Homozygosity Are Enriched
for Deleterious Variation
Zachary A. Szpiech,1,2,* Jishu Xu,3 Trevor J. Pemberton,2,4 Weiping Peng,3 Sebastian Zo¨llner,5,6
Noah A. Rosenberg,2,7 and Jun Z. Li3,7
Exome sequencing offers the potential to study the population-genomic variables that underlie patterns of deleterious variation. Runs of
homozygosity (ROH) are long stretches of consecutive homozygous genotypes probably reflecting segments shared identically by
descent as the result of processes such as consanguinity, population size reduction, and natural selection. The relationship between
ROH and patterns of predicted deleterious variation can provide insight into the way in which these processes contribute to the main-
tenance of deleterious variants. Here, we use exome sequencing to examine ROH in relation to the distribution of deleterious variation in
27 individuals of varying levels of apparent inbreeding from 6 human populations. A significantly greater fraction of all genome-wide
predicted damaging homozygotes fall in ROH than would be expected from the corresponding fraction of nondamaging homozygotes
in ROH (p < 0.001). This pattern is strongest for long ROH (p < 0.05). ROH, and especially long ROH, harbor disproportionately more
deleterious homozygotes than would be expected on the basis of the total ROH coverage of the genome and the genomic distribution of
nondamaging homozygotes. The results accord with a hypothesis that recent inbreeding, which generates long ROH, enables rare dele-
terious variants to exist in homozygous form. Thus, just as inbreeding can elevate the occurrence of rare recessive diseases that represent
homozygotes for strongly deleterious mutations, inbreeding magnifies the occurrence of mildly deleterious variants as well.Introduction
The study of deleterious variation in the genome has
fundamental importance to evolutionary genetics.1–15 In
humans, it has been argued that an individual genome
can contain tens to hundreds of variants that would be
lethal in homozygous form2,3 and hundreds to thousands
of mildly deleterious variants,6–8,15–19 the accumulation of
which could potentially have health consequences.20
Because the distribution of these variants across individ-
uals and populations reflects the result of natural selection
and other population-genomic processes, investigations of
patterns of deleterious variation can contribute insights
into human adaptation, evolution, and genetic disease.
As genomic data became available, initial studies relied
on limited numbers of genes to make inferences about
the accumulation, distribution, and effects of deleterious
variation. For example, Eyre-Walker and Keightley5
analyzed 46 genes by using sequences of human, chim-
panzee, and the gene-specific closest available primate spe-
cies at the time of the study to estimate the deleterious
mutation rate in humans. Fay et al.6 used single-nucleotide
polymorphism and divergence data from >100 genes to
estimate that 80% of amino acid mutations are deleterious
and that each diploid genome possesses ~300 deleterious
variants.
With the widespread availability of next-generation
sequencing technology, exome sequencing now allows
for the simultaneous study of nearly all known protein-1Department of Bioengineering and Therapeutic Sciences, University of Califo
Stanford University, Stanford, CA 94305, USA; 3Department of Human Gene
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90 The American Journal of Human Genetics 93, 90–102, July 11, 201coding regions. Because nonsynonymous mutations
within protein-coding regions are particularly likely
to be disruptive—by altering the encoded amino acid
sequence—relative to noncoding regions, exome se-
quences can be used together with computational tools
that assess the functional impact of amino acid changes
for studying the genomic distribution of potentially dele-
terious variation.10,21 For example, Lohmueller et al.8
examined exomic data on 20 European Americans and
15 African Americans, finding that a greater number of ho-
mozygous variants were predicted to be deleterious in the
European Americans compared to the African Americans.
Tennessen et al.15 sequenced the exomes of more than
2,000 individuals, arguing that a large fraction of coding
variation is recent, rare, and deleterious. In a study of 69
genome sequences, Torkamani et al.17 extended the work
of Lohmueller et al.8 to further characterize variation in
the number of deleterious genotypes among individuals
from different human populations.
Examining the relationships between patterns of delete-
rious variation and population-genomic variables enables
assessments of evolutionary processes that shape delete-
rious variation. For example, by using whole-genome
sequences, Lohmueller et al.11 studied correlations among
a variety of genomic variables related to coding variation,
suggesting that a positive correlation between neutral
diversity and recombination rate is the result of negative
selection acting on large numbers of weakly deleterious
variants.rnia, San Francisco, San Francisco, CA 94158, USA; 2Department of Biology,
tics, University of Michigan, Ann Arbor, MI 48109, USA; 4Department of
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Figure 1. ROH Coverage across Individual Genomes
The y axis gives the percentage of individual genomes covered by
short (class A), medium (class B), and long (class C) ROH. Numbers
on the x axis represent identification numbers in the HGDP-CEPH
diversity panel.36Recent progress in the study of runs of homozygosity
(ROH)22–29 provides a new basis for assessing the mecha-
nism by which selection produces patterns of deleterious
alleles. ROH regions—long stretches of consecutive homo-
zygous genotypes, probably resulting from identity by
descent as the result of demographic processes that reduce
population size and increase homozygosity, cultural prac-
tices that promote consanguineous marriages, and natural
selection that purges deleterious variants or elevates the
frequencies of haplotypes surrounding a favored allele—
are known to contain recessive disease mutations, and
they have been a central focus of homozygosity mapping
studies of recessive diseases.30–33 Pemberton et al.29
recently characterized worldwide patterns of ROH across
the genome, separating ROH into length classes designed
to represent the outcomes of different evolutionary forces,
and reporting a database for additional analysis.
In light of the importance of ROH regions for recessive
disease, we aim to characterize patterns of deleterious vari-
ation occurring inside and outside ROH regions. Specif-
ically, we examine two hypotheses about the processes
that shape patterns of deleterious variation in the human
genome. First, a diploid genome with an ROH region con-
taining many deleterious variants would carry these vari-
ants as homozygotes and would probably show reduced
fitness, especially if the variants interact synergistically.
As a result, this genomewould be less viable than a genome
whose ROH carry fewer deleterious homozygotes, and it is
less likely to be extant in a population. Wemight therefore
expect that random healthy individuals will carry an
underrepresentation of deleterious homozygotes within
their ROH. We can thus propose hypothesis 1: counting
deleterious and neutral variants inside and outside of
ROH regions, we expect to observe a smaller fraction of
all genome-wide deleterious homozygotes in ROH regions
compared to the fraction of neutral homozygotes occur-
ring in ROH regions. Although deleterious homozygotesThe Aoccurring outside of ROH regions will also incur a fitness
cost, under this hypothesis, we expect that selection would
more effectively purge homozygous regions if they carry
more deleterious homozygotes. Consequently, ROHwould
be likely to contain fewer deleterious homozygotes as a
proportion of all genome-wide deleterious homozygotes
compared to their corresponding proportion of neutral
homozygotes. This hypothesis implicitly requires that
the negative impact of the deleterious homozygotes be
strong and immediate or that the ROH regions be suffi-
ciently stable across generations to accumulate the effect
of selection.
Our second hypothesis proposes that low-frequency
variants are more likely to be deleterious than common
variants15,19,34,35 and that ROH regions can present low-
frequency variants in homozygous form at a higher rate
than non-ROH regions. Consider a rare variant that has
allele frequency p in a population. If this variant were to
occur in a nonidentical-by-descent region of a genome,
then it would be in homozygous form with probability
p2. If it instead occurred in an identical-by-descent ROH
region, it would be homozygous with probability p, which
exceeds p2. When homozygous deleterious variants are not
lethal and inbreeding is recent, selection will not have had
enough time to eliminate deleterious variants in ROH
regions. In this case, we expect that when sampling a
random set of individuals, we will observe an overrepre-
sentation of deleterious homozygotes inside of ROH
and inside long ROH in particular. Therefore we form
hypothesis 2: counting deleterious and neutral variants
inside and outside of ROH regions, we expect to observe
a larger fraction of deleterious homozygotes in ROH
regions compared to the fraction of neutral homozygotes
occurring in ROH regions. We further expect that longer
ROH, made of newer haplotypes, might have a higher
relative fraction of deleterious homozygotes than shorter
ROH, made of older haplotypes. Note that hypothesis 2
predicts an opposite pattern to that predicted by
hypothesis 1.
To test these hypotheses, we perform whole-exome
sequencing and computational prediction of deleterious-
ness, analyzing the predictions in conjunction with
genomic ROH patterns previously estimated in the same
individuals via SNP genotyping.29 We select 27 individuals
from 6 populations, covering a wide range of genome-wide
ROH coverage (4%–46%) and representing the extreme
ends of the ROH distribution across the genome (Figure 1).
The individuals are drawn from the HGDP-CEPH diversity
panel of apparently healthy subjects collected for popula-
tion-genetic studies.36 To predict whether a variant allele
is deleterious, we use the PolyPhen2 program.37 For neutral
variation, we consider both synonymous sites and
missense sites predicted to be benign. Next, with the coor-
dinates of called ROH regions,29 we count the number of
predicted deleterious variants that lie in each individual’s
ROH. Finally, we determine whether deleterious homozy-
gotes occur within ROH more frequently than expectedmerican Journal of Human Genetics 93, 90–102, July 11, 2013 91
from the pattern of occurrence of neutral homozygotes,
and we examine whether this pattern differs across ROH
length classes chosen to largely reflect different popula-
tion-genetic processes.Materials and Methods
We adapted a three-stage variant calling and quality control pipe-
line from DePristo et al.38 (Figure S1 available online). First, we
mapped raw sequencing reads to the reference genome and per-
formed quality control on the reads before single-nucleotide
variant sites were called. Next, we called variant sites by using all
samples jointly. Finally, we performed quality control at the site
and genotype levels for all individuals. To assess whether a variant
allele might have a deleterious effect, we computationally pre-
dicted deleteriousness with PolyPhen2.37 ROH data were taken
directly from Pemberton et al.29Raw Read Processing and Variant Calling
We performed Nimblegen SeqCap EZ v.1 (Roche Nimblegen)
exome capture followed by sequencing with the Illumina
Hiseq2000 system with one lane per sample. We aligned raw reads
to the human reference sequence (assembly hg18; UCSC Genome
Browser) with BWA39 and marked duplicate reads with Picard
tools. We used the Genome Analysis Tool Kit (GATK) v.1.2-440
for lane-level local realignment around known and possible
insertion-deletions (indels) and for lane-level recalibration of
base quality scores. Finally, we called variants by using all samples
jointly with the UnifiedGenotyper module of GATK with a mini-
mum phred-scaled confidence score of 30 (minimum estimated
error of 0.001). This analysis gave us a set of raw variant sites. In
these analyses, we considered only biallelic single-nucleotide
variant sites, and we excluded indels and multiallelic sites. The
study was approved by the institutional review board of the
University of Michigan Medical School; informed consent infor-
mation appears in Cann et al.36Quality Control of Called Variant Sites
The raw set of variant sites is expected to contain true variant sites
but also to contain many false positives. We further filtered the
initial set of variant calls to reduce false positives (Figure S1).
The Nimblegen SeqCap EZ v.1 platform targets more than
175,000 coding exons with 100 bp padding into intronic seg-
ments flanking the targeted exons, and we retained only called
variant sites that fell in the targeted regions or the padding. In
principle, we expect a putative variant site that strongly deviates
from the distribution of quality measures of known variant sites
to be a likely false positive. We therefore utilized the variant qual-
ity score recalibrator module of GATK38 to build an adaptive error
model using known variant sites that occur in our data set and
their quality measure annotations (i.e., RMS Mapping Quality,
Fisher’s exact test for strand bias, etc.). Utilizing the variant site
quality measure from the joint variant calling step above, we esti-
mated the probability that our called variant sites are true genetic
variants.
The variant quality score recalibrator requires a set of likely true
variant sites to train its error model. We considered two sets of
likely true variant sites: called exome variant sites previously iden-
tified as HapMap 3.3 variant sites with a phred-scaled prior of 15
(96.84%), and called exome variant sites previously identified as92 The American Journal of Human Genetics 93, 90–102, July 11, 201Omni 2.5M HapMap variant sites with a phred-scaled prior of 12
(93.69%), as recommended by DePristo et al.38 Given this set of
likely true variant sites, we trained the error model with the
HaplotypeScore, HRun, MQRankSum, MQ, and FS quality score
annotations.
After training the error model, all called variant sites in the data
set were annotated with the variant quality score log-of-odds
(VQSLOD), which represents the log odds of a site being a true
variant versus a false positive. We considered the distribution of
VQSLOD scores for called variant sites also found in HapMap 3.3
and chose a cut-off that returns 99% of these sites, as recommen-
ded by DePristo et al.38 After filtering sites below this cutoff,
96,797 remained (Ti/Tv ¼ 2.9821). With dbSNP build 132
(excluding sites added after build 129), 53,286 were known
(Ti/Tv ¼ 3.1017) and 43,511 were novel (Ti/Tv ¼ 2.8356).Variant Classification by Predicted Functional Impact
Some of our variant sites might not be in the coding regions of
the targeted genes because the NimbleGen platform pads the cap-
ture target by 100 bp on each side. We annotated the genomic
location of each called variable site by using the MapSNPs algo-
rithm provided with PolyPhen2.37 MapSNPs determined the
genomic location of each site with respect to the Consensus
CDS (CCDS) set of high-quality coding regions,41 and it success-
fully annotated 91,069 sites with 701 mapping to 2 CCDS regions
(Figure S2). Any site that had a mutation classified as missense in
one CCDS and as another type in another CCDS (e.g., synony-
mous) was considered only as a missense mutation for down-
stream analyses. Sites with a synonymous classification in one
CCDS and a nonsense or UTR classification in another CCDS
were removed. Sites with a missense classification in more than
one CCDS were retained for further classification by PolyPhen2.
If a missense mutation was classified by PolyPhen2 with respect
to more than one CCDS, it was retained if the classifications
were identical, and it was removed otherwise. After reconciling
these double hits and removing sites that did not fall into a
CCDS region, we were left with 26,776 missense sites and
29,914 synonymous sites.
We used PolyPhen2 to classify nonreference alleles that are
missense changes. Given a set of missense mutations, PolyPhen2
predicts the potential disruption that the nonreference allele has
on the encoded protein, incorporating knowledge of amino acid
biochemistry, folded structure (if known), and conservation score.
It does not use any population genetics information. PolyPhen2
categorizes missensemutations as ‘‘probably damaging,’’ ‘‘possibly
damaging,’’ or ‘‘benign.’’ In some analyses, we combine synony-
mous sites with benign sites into a ‘‘nondamaging’’ superclass
and possibly damaging and probably damaging sites into a
‘‘damaging’’ superclass. Although truly damaging variants might
occur in the nondamaging class and nondamaging variants might
occur in the damaging class, our concern is not with the prediction
accuracy for any particular variant; rather, we aim to study
genome-wide trends by generating classes that are separately
enriched for damaging and nondamaging variants. Note that
although the computational prediction of deleteriousness clas-
sifies the individual mutation that differs from the human
genome reference sequence, for convenience we refer to a site as
synonymous, probably damaging, possibly damaging, or benign
if the nonreference allele at that site (also known as the ‘‘alternate’’
allele) has been classified as such. Reference alleles at damaging
sites are not predicted to be damaging.3
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Figure 2. PolyPhen2 Classification of the Final Set of 54,359
Variants after All FilteringThe final set of missense mutations classified by PolyPhen2
appears in Figure S3. Because we aim to examine both deleterious
and nondeleterious variation, the final coding variation data set
used in downstream analyses consists of the PolyPhen2-classified
missense sites and the synonymous sites. The 979 missense sites
for which PolyPhen2 was unable to predict a functional effect
were removed from the data set.
Genotype-level Quality Control
Although site-level quality control generates a set of sites that are
likely to be truly variable, specific genotypes might have poor
quality. Therefore, we performed a final round of quality control
per individual genotype on the remaining 29,914 synonymous
and 25,797 missense sites. We assessed concordance with known
genotypes for all 27 sampled individuals by comparing called
genotypes at 6,180 variant sites previously studied via Illumina
SNP genotyping.42 The percentage of called exome genotypes
that agreed with the SNP genotypes was 99.2%; the concordance
was 99.3% for called nonreference homozygotes, 99.5% for called
reference homozygotes, and 98.7% for called heterozygotes (Table
S1). Conversely, the percentage of SNP heterozygotes that were
called as heterozygotes in the exome data was 98.4%. Considering
these concordance levels, we chose a filter for homozygous geno-
types of DP < 3, where DP is the read depth for the sample at that
site. Applying this filter gave a new concordance rate of 99.6% for
nonreference homozygous genotypes, while removing 42.6% of
mismatches and only 1.1% of matches.
To filter heterozygous genotypes to achieve a similar concor-
dance rate, we considered the distribution of called heterozygotes
as a function of both DP and nonreference allele frequency,
choosing, by hand, a progressive filter based on nonreference
allele frequency as a function of DP. The cutoff is more permissive
at lower DP andmore restrictive at higher DP (Figure S4). Applying
this filter produced a new concordance rate of 99.6% for heterozy-
gous genotypes, removing 71.7% of mismatches and 0.5% of
matches. Conversely, after filtering, 99.1% of Illumina heterozy-
gotes were called as heterozygotes in the sequencing data. After
filtering, 64 former variant sites did not have variant calls for
any individual (all genotypes missing), and 1,288 were monomor-
phic. These sites were removed from the data set. After this finalThe Agenotype filtering step, the data set has 54,359 sites (Figure 2).
The mean coverage ranges from 383 and 813 across individuals,
and the percentage of sites with R203 coverage ranges from
62% to 90% (Table S2).
Nonsense Variants
We also analyzed two data sets of nonsensemutations in our set of
27 individuals. The 264 sites with nonsense mutations in our data
were subjected to the same quality control filtering as synony-
mous and missense mutations above, and 7 failed. Our first data
set consists of all 257 nonsense sites that passed quality control.
Our second data set consists of 66 nonsense sites that lie in the
intersection of all 257 nonsense sites with the list of validated
loss-of-function mutations from MacArthur et al.14
Runs of Homozygosity
Pemberton et al.29 characterized worldwide patterns of runs of
homozygosity in 1,839 human individuals across 64 populations
by an autozygosity-based LOD score method. They further classi-
fied these ROH into three categories designed to correspond to
ROH that arose largely from different processes. Short ROH (class
A) are tens of kilobases in size and reflect homozygosity of ancient
haplotypes that predate continental migrations. Medium ROH
(class B) are hundreds of kilobases to a few megabases long and
mostly arise from background relatedness within populations.
Finally, long ROH (class C) are several megabases long and prob-
ably result from recent parental relatedness. For the 27 individuals
in our exome sequencing data set, we took the coordinates
defining the ROH regions as well as the ROH size class boundary
values so that we could identify a given ROH segment as belonging
to a particular size class. With this information, we calculated
Gi;j ¼ total length of ROH regions of class j in individual i
total length of the genome
:
(Equation 1)
This quantity represents the total fraction of the genome of
individual i covered by any ROH region (j¼ R) or the total fraction
of the genome covered by a specific ROH class (j˛fA;B;Cg; Table
S3). With this information, for each individual, we mapped each
variant site from Figure 2 to a specific ROH segment.Results
Data Set
We sequenced the exomes of 27 individuals to an average
read depth of 383–813. After variant calling and filtering,
our data consist of 54,359 single-nucleotide sites for which
at least 1 of the 27 individuals had a high-confidence non-
reference allele called (Figure 2). At each site, every individ-
ual’s genotype is called, and low-confidence calls are
considered missing genotypes. The per-individual missing
data rate has a mean of 3.3% and a maximum of 10.6%.
The concordance rate with SNP genotype data on the
same samples, across 6,180 sites that overlap between the
sequencing-based variant calls and genotype positions,
treating diploid genotypes as concordant if they are iden-
tical and discordant otherwise, is 99.6% for both heterozy-
gotes and nonreference allele homozygotes and 99.7% for
reference homozygotes.merican Journal of Human Genetics 93, 90–102, July 11, 2013 93
Heterozygous Genotypes in Different ROH Size Classes
We partitioned the genotypes in our data set into those
occurring at damaging versus nondamaging sites and
also those occurring outside ROH regions or inside ROH
of a specific size class. An individual’s genotype at a site
can be either homozygous for the reference allele (0/0),
heterozygous (0/1), or homozygous for the alternate allele
(1/1), and the alternate allele can be classified as damaging
or nondamaging. For individual i, across all sites we denote
by gn;ki and g
d;k
i the total number of sites with k˛f0;1;2g
alternate alleles at nondamaging and damaging sites,
respectively. For individual i, gn;ki;j and g
d;k
i;j represent the
total number of sites with k˛f0; 1;2g alternate alleles fall-
ing in ROH class j˛fA;B;C;R;Ng at nondamaging and
damaging sites, respectively. A, B, and C indicate the
ROH classes of Pemberton et al.,29 R is the union of all
three ROH classes, and N represents sites located outside
of any ROH region. Thus,
gn;ki;R ¼ gn;ki;A þ gn;ki;B þ gn;ki;C (Equation 2)
gd;ki;R ¼ gd;ki;A þ gd;ki;B þ gd;ki;C (Equation 3)
gn;ki;N ¼ gn;ki  gn;ki;R (Equation 4)
gd;ki;N ¼ gd;ki  gd;ki;R : (Equation 5)
By definition of ROH, heterozygotes occur less often
within ROH than outside ROH. To account for possible
genotyping errors and recent mutations, the approach of
Pemberton et al.29 allows a nonzero number of heterozy-
gotes to lie in an ROH.We expect to observe the fewest het-
erozygotes in long class C ROH, because these are the most
confidently identified ROH, and the haplotypes that form
these ROH have had the shortest length of time in which
to develop mutations. Conversely, we expect to see an
enrichment of heterozygotes in non-ROH regions relative
to the genome-wide prevalence. To examine these expecta-
tions, we calculate the genome-wide fraction of heterozy-
gotes in individual i as
Hi ¼ g
d;1
i þ gn;1i
P2
k¼0

gd;ki þ gn;ki
: (Equation 6)
Similarly, we calculate
Hi;j ¼
gd;1i;j þ gn;1i;j
P2
k¼0

gd;ki þ gn;ki
; (Equation 7)
representing the fraction of genotypes that are heterozy-
gotes in individual i that do not occur in an ROH region
(j ¼ N), that occur in any ROH region (j ¼ R), or that occur
in an ROH region of a particular size class (j˛fA;B;Cg).
We observe, as expected, that the percentage of hetero-
zygotes in any ROH region is substantially lower than94 The American Journal of Human Genetics 93, 90–102, July 11, 201genome-wide and in non-ROH regions (Table 1). As we
move from short to long ROH, the heterozygote percent-
age drops dramatically. This result is consistent with the
view that short (class A) ROH aremade of older haplotypes,
which have had time to accumulate more mutations, and
long (class C) ROH are made of younger haplotypes, which
have accumulated fewer mutations. In these analyses, we
consider only the 54,359 sites polymorphic in our 27 indi-
viduals, so that the denominator in heterozygote percent-
ages does not include the far greater number of sequenced
sites at which all 27 samples showed the homozygous
reference genotype. Absolute heterozygote frequencies
are therefore much lower than the values in Table 1.
Number of DamagingHomozygous Genotypes in ROH
Tables S4 and S5 report the counts for reference homozy-
gotes (0/0), heterozygotes (0/1), and nonreference homo-
zygotes (1/1) at damaging and nondamaging sites, respec-
tively, that fall into ROH regions and non-ROH regions (all
gd;ki;j and g
n;k
i;j ). For nondamaging sites, the ordering across
populations by number of homozygotes per individual
genome is consistent with known levels of genetic diver-
sity in these populations,42–44 with the African popula-
tions having higher diversity and fewer homozygotes
than the Native American populations. This trend also
holds for nonreference homozygotes that are predicted
to be damaging, with a large share of those genotypes fall-
ing in ROH regions.
These results underscore the substantial mutational
burden many individuals are carrying, particularly the in-
dividuals with a high genomic ROH content. For instance,
Surui individual 837 has the highest ROH coverage (46.4%
of the genome) and carries a total of 357 predicted
damaging variants in homozygous form (189 probably
damaging and 168 possibly damaging). By contrast, Biaka
individual 459 has the lowest ROH coverage (4.0% of
the genome) and has 212 predicted damaging variants
in homozygous form (109 probably damaging and 103
possibly damaging).
For each individual, Figure 3 shows the total number of
damaging nonreference homozygotes (1/1) as a function
of the total fraction of the genome covered by ROH (Gi;R,
Equation 1). The red points represent damaging homozy-
gotes that occur within ROH (gd;2i;R ), and the black points
represent damaging homozygotes that occur outside
ROH (gd;2i;N ). As the genome is increasingly covered by
more ROH and longer ROH (high values of Gi;R), we expect
a greater number of homozygotes (damaging or not) to fall
within ROH. We indeed see a strong linear relationship
between the number of damaging homozygotes and
genomic ROH fraction (Pearson r ¼ 0.9897, slope 584.3,
intercept 9.2). Similarly, we expect the number of homo-
zygotes occurring outside ROH to decrease with genomic
ROH fraction, because the genome simply contains
fewer ROH-free regions. As expected, we see a strong
negative correlation of damaging homozygotes outside
ROH with genomic ROH fraction (Pearson r ¼ 0.8378,3
Table 1. Percentage of All Polymorphic Exon Variants that Are Heterozygous in a Given Region of an Individual’s Genome
Population Individual ID
Genome-wide
(%, Hi)
Non-ROH
(%, Hi;N)
Any ROH
(%, Hi;R)
Class A
(%, Hi;A)
Class B
(%, Hi;B)
Class C
(%, Hi;C)
San 991 17.7 18.8 4.2 6.4 4.7 0.6
992 17.4 18.5 2.6 5.8 2.8 0.4
Biaka 454 17.9 18.5 2.6 3.8 2.7 0.2
457 18.0 18.6 3.3 5.5 2.6 2.2
458 17.2 18.1 2.1 4.7 1.8 0.2
459 17.9 18.6 1.7 3.4 1.1 0.0
460 17.6 18.1 4.6 5.7 7.6 1.0
Mozabite 1264 14.6 15.9 2.3 2.6 2.9 1.2
1267 14.7 16.1 2.4 4.1 2.2 0.8
1274 15.6 16.8 2.4 3.4 2.5 0.1
Maya 854 11.4 14.6 2.6 2.7 2.6 1.0
855 10.8 14.6 2.2 2.8 2.0 1.1
856 11.2 14.3 2.3 2.9 1.9 1.7
860 12.8 15.0 2.7 3.4 2.2 1.9
868 12.0 14.9 2.5 2.8 2.3 1.5
Karitiana 999 9.1 14.3 1.9 2.9 2.3 0.4
1012 8.8 14.2 1.8 3.0 2.6 0.3
1014 9.4 14.2 1.8 2.6 2.2 0.3
1015 9.1 14.2 1.7 2.6 2.2 0.4
1018 8.1 13.7 1.4 2.9 2.0 0.6
1019 9.9 14.2 2.1 3.0 1.8 0.3
Surui 837 8.3 14.6 1.5 2.8 2.1 0.3
838 9.6 14.6 2.3 3.6 2.4 0.7
843 8.6 13.7 1.7 3.1 1.6 0.6
845 8.7 14.2 1.9 3.2 2.3 0.7
846 9.1 14.8 1.8 3.3 2.2 0.4
849 8.8 14.5 1.6 2.9 1.8 0.5slope 139.0, intercept 181.3). The decreasing slope for
non-ROH regions is shallower than the increasing slope
for ROH regions, however, indicating that the rise in
damaging homozygotes in ROH regions outpaces the
decline of damaging homozygotes in non-ROH regions.
The fitted lines predict that an average noninbred individ-
ual (Gi;Rz0) carries approximately 181 damaging variants
in homozygous form. Increasing the ROH coverage of
the genome by 10% results in amean increase of damaging
homozygotes in ROH regions by 58 and amean decrease of
damaging homozygotes in non-ROH regions by 14, for a
net increase of 44.Damaging and Nondamaging Homozygotes in ROH
of Any Size
We next turn to testing the two hypotheses regarding the
role of selection on patterns of deleterious variation. RecallThe Athat our expectations center around comparing the frac-
tion of damaging homozygotes inside and outside of
ROH regions to the corresponding fraction of nondamag-
ing homozygotes. Under hypothesis 1, damaging homozy-
gotes occur more often in non-ROH regions relative to the
proportion of genome-wide nondamaging homozygotes
occurring in non-ROH regions. Under hypothesis 2,
damaging homozygotes occur more often in ROH regions
relative to the proportion of genome-wide nondamaging
homozygotes occurring in ROH regions. Hypothesis 2
additionally predicts an effect of ROH size class, with
long ROH having the greatest enrichment of damaging
homozygotes.
To test these hypotheses, we compute
f ni;R ¼
gn;2i;R
gn;2i
; (Equation 8)merican Journal of Human Genetics 93, 90–102, July 11, 2013 95
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Figure 3. The Number of Damaging Nonreference Homozy-
gotes versus the Fraction of the Genome Covered by ROH for
Each Individual
Red points represent the number of damaging homozygotes fall-
ing within ROH regions, and black points represent the number
of damaging homozygotes falling outside ROH regions.where f ni;R is the fraction of nondamaging 1/1 homozygotes
in individual i that fall in any ROH region. These numbers
represent the baseline distribution for nondamaging
homozygotes with which we compare the distribution of
damaging homozygotes. Similarly, we compute
f di;R ¼
gd;2i;R
gd;2i
; (Equation 9)
where f di;R is the fraction of damaging 1/1 homozygotes
in individual i that fall in any ROH region. Under hypoth-
esis 1, we expect f ni;R > f
d
i;R, whereas under hypothesis 2,
f ni;R < f
d
i;R.
Figure 4A plots f di;R and f
n
i;R versus total genomic ROH
coverage (Gi;R). Both the fraction of nondamaging homo-
zygous genotypes in ROH and the fraction of damaging
homozygous genotypes in ROH are positively correlated
with total genomic ROH coverage (nondamaging Pearson
r¼ 0.9983, damaging Pearson r¼ 0.9938). The correlations
are expected, given that we expect a larger fraction of
homozygous genotypes to occur in ROH as ROH comprise
increasingly more of the genome. In accordance with
hypothesis 2, the fraction f di;R of genome-wide damaging
homozygotes in ROH consistently exceeds the fraction
f ni;R of genome-wide nondamaging homozygotes in ROH.
To assess the statistical significance of the two linear
regressions on total genomic ROH coverage for the
damaging and nondamaging genotypes, we fit a linear
model,
fi;R ¼ b0 þ b1Gi;R þ b2Di þ b3Gi;RDi þ e; (Equation 10)
where fi;R is a vector of length 54 containing, for all individ-
uals, the fraction of genome-wide damaging homozygotes
in any ROH region (f di;R) and the fraction of genome-wide
nondamaging homozygotes in any ROH region (f ni;R). Gi;R
is the fraction of the genome covered by ROH of any size96 The American Journal of Human Genetics 93, 90–102, July 11, 201for individual i, as given in Equation 1, and Di is an indica-
tor variable, taking a value of 1 if the observed response is
of damaging homozygotes and a value of 0 for nondamag-
ing homozygotes. A statistically significant b2 (two-tailed
t test) indicates a difference in the intercepts of separate re-
gressions for damaging and nondamaging homozygotes,
and a statistically significant b3 (two-tailed t test) indicates
a difference in the regression slopes.
We find b2 ¼ 0:05340 (p ¼ 8.591 3 106) and
b3 ¼ 0:09647 (p ¼ 8.394 3 103), indicating significantly
different intercepts and slopes between the regressions in
Figure 4A. Thus, as predicted by hypothesis 2, damaging
homozygotes occur more often in ROH than expected on
the basis of nondamaging homozygotes.Damaging and Nondamaging Homozygotes by ROH
Size Class
Under hypothesis 2, we expect to observe an excess of
damaging homozygotes compared to nondamaging
homozygotes specifically in long (class C) ROH, and an
excess of damaging homozygotes in long (class C) ROH
versus damaging homozygotes in short (class A) ROH. To
examine these predictions, we separately consider each
ROH size class. For homozygous genotypes falling in
ROH of size class j, we calculate
f di;j ¼
gd;2i;j
gd;2i
(Equation 11)
f ni;j ¼
gn;2i;j
gn;2i
; (Equation 12)
for damaging and nondamaging 1/1 homozygotes, respec-
tively. Because we investigate the same number of data
points for each size class—27 individuals, eachwith a value
of f di;j and a value of f
n
i;j—statistical tests for each size class
are equally powered.
Figure 4B plots f di;A and f
n
i;A versus total genomic coverage
for class A ROH (Gi;A). Both the fraction of nondamaging
homozygous genotypes in class A ROH and the fraction
of damaging homozygous genotypes in class A ROH are
positively correlated with class A genomic coverage (non-
damaging Pearson r ¼ 0.9829, damaging Pearson r ¼
0.9365), though the two regressions have no significant
difference in either the intercept (b2 ¼ 0:01137, p ¼
0.3027) or the slope (b3 ¼ 0:05119, p ¼ 0.6466). Figure 4C
plots f di;B and f
n
i;B versus total genomic coverage by class B
ROH (Gi;B). The regressions for nondamaging (r ¼
0.9892) and damaging (r ¼ 0.9629) homozygotes have
smaller p values than in the case of class A, but again
with no significant difference in either the intercept
(b2 ¼ 0:01540, p ¼ 0.1312) or the slope (b3 ¼ 0:1283, p ¼
0.1425). Figure 4D plots f di;C and f
n
i;C versus total genomic
coverage by class C ROH (Gi;C) and the regressions for non-
damaging (r¼ 0.9921) and damaging (r¼ 0.9727) homozy-
gotes. We now find a significant difference in both the3
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Figure 4. The Fraction of All Genome-
wide Nonreference Homozygotes Falling
in ROH Regions versus the Fraction of
the Genome Covered by ROH, for Each
Individual
(A) Any ROH region.
(B) Short (class A) ROH regions.
(C) Medium (class B) ROH regions.
(D) Long (class C) ROH regions.
Red points represent damaging homozy-
gotes, and blue points represent nonda-
maging homozygotes.intercept (b2 ¼ 0:01862, p ¼ 0.03679) and slope (b3 ¼
0:2127, p ¼ 0.01863). These results are consistent with
hypothesis 2, supporting the view that inbreeding that
generates long ROH is driving the differences in the pro-
portions of damaging and nondamaging homozygotes in
ROH regions.
Under hypothesis 2, we expect damaging homozygotes
to occur more frequently in class C ROH than in class A
ROH. We compare the fraction of damaging homozygotes
falling in class C ROH (f di;C) to the fraction of damaging
homozygotes falling in class A ROH (f di;A). We can see in
Figure 5 that the high-ROH-coverage individuals have a
substantially higher fraction of genome-wide damaging
homozygotes occurring in class C versus class A. We test
the statistical significance of the difference of these regres-
sions with a linear model analogous to Equation 10. Here,
however, we are concerned with distinguishing the distri-
butions of damaging homozygotes in ROH of classes C
and A. The regression model now becomes
f di ¼ b0 þ b1Gi þ b2Ci þ b3GiCi þ e; (Equation 13)
where f di is a vector of length 54 containing, for all individ-
uals, the fractions of genome-wide damaging homozygotes
in class C ROH (f di;C) and class A ROH (f
d
i;A). Gi is the fraction
of the genome covered by either class C (Gi;C) or class A
(Gi;A) ROH for individual i, and Ci is an indicator variable,
taking a value of 1 if the observed response is of damaging
homozygotes in class C ROH and a value of 0 if the
observed response is of damaging homozygotes in class A
ROH. Although the intercepts of the regressions are not
significantly different (b2 ¼ 4:4633103, p ¼ 0.7278), theThe American Journal of Humslopes are significantly different
(b3 ¼ 0:3295, p ¼ 0.01389). This
result suggests that the increase in
the fraction of damaging homozy-
gotes is higher per unit increase in
ROH coverage for class C ROH
versus class A ROH, consistent with
hypothesis 2.
To assess the robustness of these re-
sults, we repeated the analysis with
SIFT, an alternative program for pre-
dicting deleterious alleles.45 SIFT gen-
erates two classifications, toleratedand damaging, analogous to our use of nondamaging
and damaging classes with PolyPhen2. In general, SIFT
produces the same patterns observed with PolyPhen2 (Fig-
ures S5 and S6). With PolyPhen2, we found significant
differences between the nondamaging and damaging
intercepts and slopes when considering all ROH regions
and class C ROH regions, and we further found a signifi-
cant difference in the slopes when comparing damaging
homozygotes in class A versus class C ROH. All of these re-
sults are recapitulated with SIFT, with the exception that
for the comparison of intercept terms for nondamaging
and damaging variants, PolyPhen2 produced a result sig-
nificant at the 0.05 level (p ¼ 0.03679) whereas with
SIFT, the test is not significant (p ¼ 0.06029).
The divergence in slopes in Figure 5 might be driven
partly by an excess of damaging variants in Native Amer-
ican populations as a function of all Native American var-
iants, compared to the analogous computation in African
populations. To examine this possibility, for each popula-
tion in our data set, we consider the fraction of popula-
tion-specific (private) alternate alleles that are predicted
to be damaging. Here, we call a site private if the alternate
allele at that locus is found in only one of the populations
in our sample. For each population, we calculate the pro-
portion of alleles private to the population that are of a
particular predicted functional class by computing
Fp;s ¼ Np;s
Np
; (Equation 14)
where Fp;s is the fraction of alleles private to population
p that have predicted functional class s˛{synonymous,an Genetics 93, 90–102, July 11, 2013 97
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Figure 6. The Fraction of All Private Nonreference Variants that
Are Synonymous or Missense Variants
Private variants are defined as variants for which the nonreference
allele appears only in a single population in our sample. Missense
variants are further split by PolyPhen2 into predicted benign,
predicted possibly damaging, and predicted probably damaging
classes.
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Figure 5. The Fraction of All Genome-wide Nonreference
Homozygotes Falling in Different Sized ROH versus the Fraction
of the Genome Covered by ROH, for Each Individual
Orange points represent damaging homozygotes in long (class C)
ROH regions, and green points represent damaging homozygotes
in short (class A) ROH regions.benign, probably damaging, possibly damaging},Np;s is the
number of alleles private to population p of predicted func-
tional class s, andNp is the total number of alleles private to
population p. Figure 6 depicts this fraction, illustrating that
the proportion of private variants that are predicted to be
damaging is lowest in sub-Saharan African populations
(~20%) and highest in the Native American populations
(>30%). The Native American populations have the
highest levels of genomic ROH coverage, and long ROH,
produced by younger haplotypes, are likely to possess a
disproportionate number of young and potentially private
variants (Figure S7). Thus, the combination of a high pro-
portion of private damaging alleles and high homozygosi-
ty is probably contributing to the significant divergence in
slopes observed in Figure 5.
Nonsense Variants and ROH
The patterns we have observed thus far consider homozy-
gotes from two predicted classes: damaging and nonda-
maging. Although we expect the damaging class of
variants to be enriched for variants that have deleterious
effects, it is useful to study a subset of variants with an
even higher likelihood of being deleterious. First, when
we consider probably damaging, possibly damaging,
benign, and synonymous homozygotes as four separate
classes rather than combining benign and synonymous
homozygotes and probably damaging and possibly
damaging homozygotes, the observed patterns are similar
to those observed in the combined analysis, with the prob-
ably damaging homozygotes having the highest fraction
within ROH and the benign and synonymous homozy-
gotes having nearly identical fractions (Figure S8). Next,
noting that nonsense mutations create stop codons in
the reading frame and are a priori more likely to interfere
with the proper functioning of a protein than are missense
mutations, we examined the placement of two nested sets
of nonsense mutations in relation to ROH. The first is a set98 The American Journal of Human Genetics 93, 90–102, July 11, 201of 257 nonsense mutations that passed our quality-control
procedures, and the second is a subset of those 257 sites
consisting of 66 nonsense mutations that are verified
loss-of-function (LoF) variants as identified by MacArthur
et al.14 Tables S6 and S7 report at nonsense and LoF
nonsense sites, respectively, the counts for reference
homozygotes (0/0), heterozygotes (0/1), and nonreference
homozygotes (1/1) that fall into ROH regions and non-
ROH regions.
Because these data sets are substantially smaller than the
full sets of damaging and nondamaging sites, instead of
considering individuals separately, we combine individ-
uals into two groups: ‘‘low-ROH’’ individuals and ‘‘high-
ROH’’ individuals. For comparisons involving all ROH
regions (Figure 7A), individuals with less than 20%
genomic ROH coverage were classified as low ROH, and
those with more than 20% ROH coverage were classified
as high ROH. For comparisons involving specific ROH
size classes (Figures 7B–7D), individuals with less than
5% genomic ROH coverage of the respective size class
were classified as low ROH, and the remaining individuals
were regarded as high ROH.
Figure 7A examines the distribution of nonsense muta-
tions across all ROH. For low-ROH individuals, no signifi-
cant difference exists in the mean fraction of homozygotes
falling in ROH between nondamaging and nonsense vari-
ants (p ¼ 0.6788, one-tailed t test) or between nondamag-
ing and LoF variants (p ¼ 0.2581, one-tailed t test). For
high-ROH individuals, however, the fraction of nonda-
maging homozygotes falling in ROH is significantly lower
than those for nonsense (p ¼ 2.368 3 103, one-tailed
t test) and LoF (p ¼ 3.160 3 104, one-tailed t test) homo-
zygotes falling in ROH. Separately analyzing class A, class
B, and class C ROH (Figures 7B–7D), for individuals with
high genomic ROH coverage, the fraction of nonsense
homozygotes in class C ROH is significantly greater than
the fraction of nondamaging homozygotes in class C3
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Figure 7. The Fraction of All Genome-
wide Nonreference Homozygotes Falling
in ROH Regions for Nondamaging
Variants, Nonsense Variants, and LoF
Nonsense Variants versus the Fraction of
the Genome Covered by ROH, for Individ-
uals Grouped into ‘‘Low-ROH’’ and ‘‘High-
ROH’’ Groups
(A) Any ROH region.
(B) Short (class A) ROH regions.
(C) Medium (class B) ROH regions.
(D) Long (class C) ROH regions.
Means that exceed the mean for benign
sites for the same ROH coverage class at
the p < 0.05 significance level are indi-
cated by asterisks.ROH (p ¼ 2.8623 103, one-tailed t test); the comparisons
are not significant for class A (p ¼ 0.4976, one-tailed t test)
or class B (p¼ 0.05689, one-tailed t test) ROH. The fraction
of nonsense LoF homozygotes significantly exceeds the
fraction of nondamaging homozygotes in class B ROH
(p ¼ 0.01203, one-tailed t test) and class C ROH (p ¼
8.931 3 103, one-tailed t test) but not in class A ROH
(p ¼ 0.8964, one-tailed t test). These results are consistent
with our hypothesis 2, in that high-ROH individuals are
observed to have a higher fraction of damaging homozy-
gotes (nonsense and LoF nonsense) occurring in ROH of
any size (Figure 7A) and that the pattern is driven primarily
by long (class C) ROH (Figure 7D).Discussion
Through sequencing-based variant discovery efforts, it has
been widely recognized that each human individual
carries numerous deleterious variants.8,14,15,18,19 Our data
set extends this observation by showing that many indi-
viduals can carry at least 147 and up to 357 such
damaging variants in homozygous form (Table S4).
Further, more than half the individuals in our sample
(14) carry five or more homozygous verified LoF variants
(Table S7). The fact that the combined presence of so
many homozygous deleterious variants is compatible
with life supports the view that most deleterious variants
must have relatively small fitness effects. The numbers
of predicted deleterious homozygotes generally accordThe American Journal of Humwith other recent studies, which
have estimated values from a few
dozen to a thousand or more.8,17,18
Because we selected samples for our
analysis to extend across the range
of genomic ROH coverage observed
worldwide, we expect that the num-
ber of deleterious variants in individ-
uals from populations that we have
not included would be comparable
to the values we report.Our analysis of deleterious variation with respect to ROH
was framed by two alternative hypotheses. Under hypoth-
esis 1, because of more effective selection in ROH against
deleterious variants, we might have expected the fraction
of genome-wide damaging homozygotes occurring in
ROH to be less than the corresponding fraction of
genome-wide nondamaging homozygotes. In this case,
the result would have been driven by the expectation
that selection would purge haplotypes containing many
deleterious recessive alleles. On the other hand, under
hypothesis 2, we expected inbreeding to present an excess
of low-frequency and damaging variants in homozygous
form, with selection not having had sufficient time to
eliminate them. Under this hypothesis, we expected
ROH to consist of long IBD haplotypes that combine
otherwise rare and probably deleterious variants into ho-
mozygotes. Because IBD regions present homozygotes at
a higher frequency than would be predicted by Hardy-
Weinberg equilibrium, we expected ROH to contain a
higher fraction of damaging homozygotes than the corre-
sponding fraction of nondamaging homozygotes, with
class C ROH—the most recent in origin and the result of
recent inbreeding—driving this difference.
As we saw in Figure 4A, the fraction of damaging homo-
zygotes was significantly greater in ROH regions than the
corresponding fraction of nondamaging homozygotes,
consistent with hypothesis 2. The pattern was observed
more strongly for medium (class B) ROH than for short
(class A) ROH, and for long (class C) ROH more strongly
than for medium (class B) ROH; for long ROH, thean Genetics 93, 90–102, July 11, 2013 99
difference was significant. Each of these patterns was
recapitulated by nonsense and LoF nonsense variants
(Figure 7).
Our identification of an enrichment of deleterious varia-
tion in ROH accords with and extends recent related work.
Studies beginning with Lohmueller et al.8 have found that
lower-diversity populations carry an excess of recessive
deleterious variants, presumably as the result of founding
events that have inflated the frequencies of otherwise
rare alleles. If the same founding events that have ampli-
fied recessive deleterious variants are responsible for
ROH, it might be expected that those variants would lie
within ROH regions that have resulted from such founder
events—typically short andmedium length ROH (classes A
and B). Although we do see some evidence for an excess of
deleterious variants in these ROH classes, the signal is
strongest for long ROH (class C), indicating a role for
both inbreeding and founder events in increasing the
occurrence of recessive deleterious variants.
We note that the excess of recessive deleterious variants
in ROH regions might also result partially from a scenario
in which positive selection generating long haplotypes
leads to production of ROH, and neighboring deleterious
variants in the ROH surrounding the positively selected
sites hitchhike to high frequencies. However, Pemberton
et al.29 found that across the genome, the frequency at
which ROH occur is only weakly correlated with haplo-
type-based scores for positive selection; thus, although
we expect that hitchhiking might account for some delete-
rious variants in ROH, this result suggests that it is unlikely
as a general explanation. Another possibility is that ROH
preferentially cover gene regions of systematically lower
genomic constraint and that deleterious alleles in ROH
are occurring in these gene regions. It is difficult to assess
this hypothesis, however, because the computational pre-
diction algorithms we used to classify deleterious muta-
tions rely on genomic constraint measures, so that we
cannot easily separate measures of constraint from predic-
tions of deleteriousness.
One of the limitations of this study was our reliance on
predicted variant function. Computational prediction
algorithms are concerned primarily with molecular func-
tions of gene products and not with overall impact on
organism-level disease risks or fitness. Thus, the PolyPhen2
prediction is only a proxy for the fitness consequence of a
mutation. Although we do not expect the functional clas-
sification given by PolyPhen2 to be accurate for every
missense variant, it is reasonable to consider the full sets
of damaging and nondamaging variants as enriched for
truly deleterious and benign mutations, respectively.
Because our study deals with these variants in aggregate,
prediction accuracy for individual variants is not as impor-
tant as the observed general trends. Our claims are robust
in that we reproduced our findings in two higher-confi-
dence sets of deleterious variants: nonsense and verified
loss-of-function variants. Furthermore, by using the pro-
gram SIFT in place of PolyPhen2 to computationally pre-100 The American Journal of Human Genetics 93, 90–102, July 11, 20dict functional effect, we reproduced our findings from
Figures 4 and 5 in Figures S5 and S6.
The human genome contains a spectrum of variants
with a rich gradation of functional impact. Our results sug-
gest that inbreeding not only amplifies the occurrence of
recessive genetic diseases of significant fitness effect, it
also amplifies the burden of mildly deleterious homozy-
gotes. Indeed, inbreeding has long been known to be dele-
terious to the health of offspring,2,46–51 and if a variant in a
population is lethal in homozygous form, inbreeding will
greatly increase the chance of generating a genome with
the lethal genotype. Our work finds that inbreeding also
has a more subtle effect, enabling the accumulation of
mildly deleterious variants as well. If some of these variants
act in synergistic fashion, then, as suggested by recent re-
sults implicating an excess of runs of homozygosity as a
contributor to disease phenotypes52 and other traits,53
the simultaneous presence of multiple deleterious variants
in homozygous form could systematically underlie an
important component of complex human diseases.Supplemental Data
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